Clinical Trials · NCT00856609
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Enrollment
- 150
- Start date
- Mar 2009
- Locations
- 1 site, United States
- Primary endpoint
- Energy Intake